Premium
AC Immune SA (ACIU)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurod... AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.24 | -10.7623318386 | 2.23 | 2.29 | 1.95 | 226826 | 2.08958745 | CS |
| 4 | -0.59 | -22.8682170543 | 2.58 | 2.59 | 1.95 | 204012 | 2.30542538 | CS |
| 12 | -0.71 | -26.2962962963 | 2.7 | 3.094 | 1.95 | 184503 | 2.53609291 | CS |
| 26 | -1.7 | -46.0704607046 | 3.69 | 3.93 | 1.95 | 147659 | 2.80426753 | CS |
| 52 | -0.96 | -32.5423728814 | 2.95 | 4.9782 | 1.95 | 331436 | 3.28066307 | CS |
| 156 | -2.41 | -54.7727272727 | 4.4 | 5.14 | 1.68 | 255640 | 3.20099011 | CS |
| 260 | -4.16 | -67.6422764228 | 6.15 | 14.89 | 1.68 | 434316 | 5.97092869 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
